FA News and Press, First Advantage Corporation

ATLANTA, March 13, 2026 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a global software and data company, today released its 2026 Global Background Screening Trends Report in partnership with ClearlyRated. Drawing on insights from more than 5,000 CHROs, HR leaders, and job seekers...

2026-03-12 14:02:19 ET First Advantage Corporation (FA) BofA Securities 2026 Information & Business Services Conference March 12, 2026 11:20 AM EDT... Read the full article on Seeking Alpha For further details see: First Advantage Corporation (FA) Presents at BofA Securi...

2026-03-06 05:03:28 ET Manav Patnaik from Barclays issued a price target of $15.00 for FA on 2026-03-06 07:53:00. The adjusted price target was set to $15.00. At the time of the announcement, FA was trading at $12.16. The overall price target consensus is at $21.00 with ...

2026-03-06 04:15:04 ET Barclays analyst issues OVERWEIGHT recommendation for FA on March 6, 2026 07:53AM ET. The previous analyst recommendation was Equal-Weight. FA was trading at $12.16 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...

2026-02-26 15:58:55 ET More on First Advantage First Advantage Corporation (FA) Q4 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on First Advantage Historical earnings data for First Advantage Financial information for First Advantage ...

2026-02-26 15:57:55 ET First Advantage Corporation (FA) Q4 2025 Earnings Call February 26, 2026 8:30 AM EST... Read the full article on Seeking Alpha For further details see: First Advantage Corporation (FA) Q4 2025 Earnings Call Transcript

2026-02-26 09:06:14 ET More on First Advantage Seeking Alpha’s Quant Rating on First Advantage Historical earnings data for First Advantage Financial information for First Advantage Read the full article on Seeking Alpha For further details see...

Evertec Inc. (EVTC) is expected to report $0.81 for Q4 2025 BioCryst Pharmaceuticals Inc. (BCRX) is expected to report $0.06 for Q4 2025 FTI Consulting Inc. (FCN) is expected to report $1.38 for Q4 2025 Arbe Robotics Ltd. (ARBE) is expected to report $-0.1 for Q4 2025 Aclaris Ther...

Fourth Quarter 2025 Highlights 1 Revenues of $420.0 million Net income of $3.5 million (0.8% margin) 2 ; Diluted Net Income Per Share of $0.02 Adjusted EBITDA of $116.8 million (27.8% margin) Adjusted Net Income of $51.9 million; Adjusted Diluted Earnings Per Share of $0.30 Cash Flows ...

2026-02-18 01:30:00 ET The following segment was excerpted from the The Optimist Fund Q4 2025 Quarterly Letter. ... Read the full article on Seeking Alpha For further details see: The Optimist Fund Q4 2025 Portfolio Review